North America Neurovascular Catheters Market Size & Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurovascular catheters market will help companies and investors design strategic landscapes.

Embolization catheters was the largest segment with a revenue share of 27.65% in 2023. Horizon Databook has segmented the North America neurovascular catheters market based on microcatheters, balloon catheters, access catheters, embolization catheters covering the revenue growth of each sub-segment from 2018 to 2030.

North America dominated the market in 2023. Its growth can be attributed to an increase in the prevalence of various neurovascular disorders such as stroke & brain aneurysms as well as rise in the demand for minimally invasive neurological procedures. Supportive government initiatives, including the establishment of American Society of Craniofacial Surgery (ASCFS), for creating awareness about minimally invasive Craniomaxillofacial (CMF) surgeries are expected to further propel the market growth during the forecast period. 

Moreover, rapid technological advancements, presence of key manufacturers in the region, increase in R&D investments, and rise in the number of government funding & initiatives are expected to contribute to market growth. For instance, the National Parkinson Foundation (NPF) provides funds to researchers and scientists to make advancements in this field. Similarly, the presence of well-established healthcare infrastructure and favorable reimbursement & regulatory policies in the healthcare industry are among the factors expected to create significant growth opportunities in the market. 

For instance, according to the Centers for Medicare & Medicaid Services (CMS), in December 2023, health spending in the U.S. is expected to grow by 4.1% to USD 4.5 trillion in 2022 and account for 17.3% of GDP. In addition, high disposable income in developed economies and availability of skilled professionals are some of the factors responsible for the large share of North America neurovascular catheters market.